UnitedHealth Group (UNH) Competitors $251.25 +10.27 (+4.26%) Closing price 03:59 PM EasternExtended Trading$251.02 -0.23 (-0.09%) As of 08:00 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock UNH vs. ALKS, MEDP, CI, CNC, CVS, ELV, HCA, HUM, JNJ, and MOHShould you be buying UnitedHealth Group stock or one of its competitors? The main competitors of UnitedHealth Group include Alkermes (ALKS), Medpace (MEDP), Cigna Group (CI), Centene (CNC), CVS Health (CVS), Elevance Health (ELV), HCA Healthcare (HCA), Humana (HUM), Johnson & Johnson (JNJ), and Molina Healthcare (MOH). These companies are all part of the "medical" sector. UnitedHealth Group vs. Its Competitors Alkermes Medpace Cigna Group Centene CVS Health Elevance Health HCA Healthcare Humana Johnson & Johnson Molina Healthcare UnitedHealth Group (NYSE:UNH) and Alkermes (NASDAQ:ALKS) are both medical companies, but which is the superior stock? We will compare the two companies based on the strength of their earnings, institutional ownership, risk, analyst recommendations, valuation, dividends, profitability and media sentiment. Do institutionals and insiders believe in UNH or ALKS? 87.9% of UnitedHealth Group shares are owned by institutional investors. Comparatively, 95.2% of Alkermes shares are owned by institutional investors. 0.3% of UnitedHealth Group shares are owned by insiders. Comparatively, 4.4% of Alkermes shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term. Is UNH or ALKS more profitable? Alkermes has a net margin of 23.15% compared to UnitedHealth Group's net margin of 5.04%. Alkermes' return on equity of 24.86% beat UnitedHealth Group's return on equity.Company Net Margins Return on Equity Return on Assets UnitedHealth Group5.04% 23.32% 7.66% Alkermes 23.15%24.86%17.14% Do analysts rate UNH or ALKS? UnitedHealth Group presently has a consensus target price of $371.67, indicating a potential upside of 47.93%. Alkermes has a consensus target price of $41.08, indicating a potential upside of 54.45%. Given Alkermes' stronger consensus rating and higher possible upside, analysts plainly believe Alkermes is more favorable than UnitedHealth Group.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score UnitedHealth Group 3 Sell rating(s) 6 Hold rating(s) 15 Buy rating(s) 0 Strong Buy rating(s) 2.50Alkermes 0 Sell rating(s) 3 Hold rating(s) 8 Buy rating(s) 1 Strong Buy rating(s) 2.83 Does the media prefer UNH or ALKS? In the previous week, UnitedHealth Group had 138 more articles in the media than Alkermes. MarketBeat recorded 167 mentions for UnitedHealth Group and 29 mentions for Alkermes. Alkermes' average media sentiment score of 0.91 beat UnitedHealth Group's score of 0.56 indicating that Alkermes is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment UnitedHealth Group 85 Very Positive mention(s) 24 Positive mention(s) 21 Neutral mention(s) 17 Negative mention(s) 6 Very Negative mention(s) Positive Alkermes 13 Very Positive mention(s) 2 Positive mention(s) 8 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Which has more volatility and risk, UNH or ALKS? UnitedHealth Group has a beta of 0.43, indicating that its share price is 57% less volatile than the S&P 500. Comparatively, Alkermes has a beta of 0.47, indicating that its share price is 53% less volatile than the S&P 500. Which has preferable earnings and valuation, UNH or ALKS? UnitedHealth Group has higher revenue and earnings than Alkermes. UnitedHealth Group is trading at a lower price-to-earnings ratio than Alkermes, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioUnitedHealth Group$400.28B0.57$14.41B$23.0810.89Alkermes$1.56B2.82$367.07M$2.0812.79 SummaryAlkermes beats UnitedHealth Group on 12 of the 17 factors compared between the two stocks. Get UnitedHealth Group News Delivered to You Automatically Sign up to receive the latest news and ratings for UNH and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding UNH and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart UNH vs. The Competition Export to ExcelMetricUnitedHealth GroupMED IndustryMedical SectorNYSE ExchangeMarket Cap$218.60B$34.26B$5.59B$20.69BDividend Yield3.67%107.85%4.73%3.67%P/E Ratio10.898.8028.8829.29Price / Sales0.571.31445.9564.14Price / Cash7.447.9235.6823.31Price / Book2.272.328.164.40Net Income$14.41B$2.64B$3.25B$995.90M7 Day Performance-3.68%-2.81%0.45%-0.85%1 Month Performance-18.61%-13.00%8.27%0.39%1 Year Performance-55.92%-37.37%30.29%16.86% UnitedHealth Group Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)UNHUnitedHealth Group4.9963 of 5 stars$251.25+4.3%$371.67+47.9%-59.2%$218.60B$400.28B10.89400,000Trending NewsEarnings ReportAnalyst ForecastShort Interest ↑ALKSAlkermes4.766 of 5 stars$26.49-5.2%$41.08+55.1%-3.9%$4.37B$1.56B12.731,800Earnings ReportAnalyst RevisionMEDPMedpace4.2094 of 5 stars$427.26-2.4%$406.60-4.8%+14.7%$12.00B$2.23B31.775,900CICigna Group4.9993 of 5 stars$266.50-10.5%$380.39+42.7%-20.8%$71.19B$254.47B14.7673,500Positive NewsEarnings ReportAnalyst DowngradeAnalyst RevisionHigh Trading VolumeCNCCentene4.9304 of 5 stars$26.06+1.1%$45.31+73.9%-66.4%$12.80B$163.07B6.4560,500Trending NewsAnalyst ForecastHigh Trading VolumeCVSCVS Health4.9978 of 5 stars$62.11-0.3%$74.94+20.7%+3.6%$78.57B$372.81B14.82300,000Trending NewsEarnings ReportAnalyst RevisionHigh Trading VolumeELVElevance Health4.9393 of 5 stars$283.04-3.6%$418.19+47.7%-48.6%$63.73B$189.25B12.04104,200Positive NewsHCAHCA Healthcare4.7342 of 5 stars$354.24-0.2%$396.46+11.9%+1.9%$85.22B$70.60B14.89316,000Trending NewsAnalyst ForecastHUMHumana4.7001 of 5 stars$249.65-4.5%$281.62+12.8%-32.1%$30.13B$120.26B17.6665,680Earnings ReportAnalyst DowngradeAnalyst RevisionJNJJohnson & Johnson4.68 of 5 stars$164.76-1.5%$174.50+5.9%+4.2%$396.81B$88.82B17.62138,100Positive NewsMOHMolina Healthcare4.9163 of 5 stars$158.04-1.2%$244.55+54.7%-55.0%$8.57B$40.65B7.7918,000 Related Companies and Tools Related Companies Alkermes Alternatives Medpace Alternatives Cigna Group Alternatives Centene Alternatives CVS Health Alternatives Elevance Health Alternatives HCA Healthcare Alternatives Humana Alternatives Johnson & Johnson Alternatives Molina Healthcare Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NYSE:UNH) was last updated on 8/5/2025 by MarketBeat.com Staff From Our PartnersMan Who Called Nvidia at $1.10 Says Buy This Now...In 2004, one man called Nvidia before just about anyone knew it existed. Now, this same guy says a new comp...The Oxford Club | SponsoredCrypto Income (almost instantly)How would you like to collect a small percentage of the $4 billion changing hands daily in the crypto market? ...Awesomely, LLC | SponsoredOne stock to replace NvidiaI'm a Futurist: Here are 3 stocks better than Nvidia Nvidia's own customers could soon become fierce compet...InvestorPlace | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredDigital Dollar Alert: Protect Your Wealth Before It’s Too Late134 countries are developing Central Bank Digital Currencies — and the U.S. is quietly testing one. Experts...American Alternative | Sponsored[Shocking New Report] U.S. Dollar To Crash?The "Death Spiral" Threatening Your Savings But this time, it's not just Dalio ringing the alarm bells…Goldco Precious Metals | SponsoredREVEALED FREE: Our top 3 stocks to own in 2025 and beyondEvery time Weiss Ratings flashed green like this, the average gain on each and every stock has been 303% (incl...Weiss Ratings | SponsoredTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding UnitedHealth Group Incorporated Please log in to your account or sign up in order to add this asset to your watchlist. Share UnitedHealth Group With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.